Get the Stockscreener App
10.79
7.47%
0.75
After Hours:
10.75
-0.04
-0.37%
Igm Biosciences Inc Stock (IGMS) Latest News
Quest Partners LLC Decreases Stock Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Shares Down 4.1%Should You Sell? - MarketBeat
How to Take Advantage of moves in (IGMS) - Stock Traders Daily
IGM Biosciences (NASDAQ:IGMS) Shares Gap DownHere's What Happened - MarketBeat
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) Price Target at $16.13 - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Will Imvotamab Data Propel IGM Biosciences To New Heights In 2025? - RTTNews
IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism - Investing.com
IGM Biosciences' SWOT analysis: stock pivot to autoimmune focus sparks analyst optimism By Investing.com - Investing.com South Africa
How To Trade (IGMS) - Stock Traders Daily
FMR LLC Increases Stake in IGM Biosciences Inc - GuruFocus.com
IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip - Simply Wall St
Biotech firm backs off its focus on oncology research - The Business Journals
IGM Biosciences (NASDAQ:IGMS) Given New $27.00 Price Target at Stifel Nicolaus - MarketBeat
Igm Biosciences: Navigating Financial Challenges Amidst Early-Stage Antibody Development - MSN
IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
IGM Biosciences (NASDAQ:IGMS) Shares Down 7.8%Here's Why - MarketBeat
IGM Biosciences Inc (IGMS) Quarterly 10-Q Report - Quartz
IGM Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
IGM Biosciences earnings missed by $0.21, revenue topped estimates - Investing.com UK
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
IGM Biosciences Reports $61.4M Loss, Extends Cash Runway to 2027 Despite Clinical Progress | IGMS Stock News - StockTitan
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewswire
(IGMS) Investment Report - Stock Traders Daily
IGM Biosciences (NASDAQ:IGMS) Shares Down 3.7%Should You Sell? - MarketBeat
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $15.00 - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading 7.7% HigherHere's Why - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook - Investing.com India
IGM Biosciences' SWOT analysis: autoimmune pivot drives stock outlook By Investing.com - Investing.com South Africa
Exchange Traded Concepts LLC Trims Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences’ stock tumbles as analysts weigh in on pivot plan with dismay - MSN
IGM Biosciences (NASDAQ:IGMS) Shares Down 6.1%Here's What Happened - MarketBeat
IGM Biosciences (NASDAQ:IGMS) PT Raised to $20.00 at Royal Bank of Canada - Defense World
AQR Capital Management LLC Acquires Shares of 12,230 IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) PT Raised to $20.00 - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Shares Up 8%Here's What Happened - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Short Interest Down 23.9% in September - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Shares Down 5.5%Time to Sell? - MarketBeat
Dimensional Fund Advisors LP Lowers Position in IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading Up 8.1%Here's What Happened - MarketBeat
Marshall Wace LLP Has $737,000 Stock Holdings in IGM Biosciences, Inc. (NASDAQ:IGMS) - MarketBeat
IGM Biosciences (NASDAQ:IGMS) Trading 10.1% Higher – Here’s What Happened - Defense World
IGM Biosciences (NASDAQ:IGMS) Trading Up 10.1%Time to Buy? - MarketBeat
1.58%
1.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):